Center for Neuroscience and Cell Biology
I am an assistant professor in Molecular Medicine at the Faculty of Medicine of Lund University and group leader of the Cell Reprogramming in Hematopoiesis and Immunity Laboratory. I have long held an interest in understanding how cell identity is acquired, maintained and ultimately modified or reversed. During my PhD, I have made my first contributions to the cellular reprogramming field by establishing cell fusion and heterokaryons as a new approach to study reprogramming mechanisms towards pluripotency. Of note I implicated the essential role of Polycomb repression in reprogramming. Then, during my postdoc, I brought cellular reprogramming concepts to hematopoeisis for the first time. I identified a combination of transcription factors that induces hemogenesis and established that cellular reprogramming approaches can inform the developmental specification of hematopoietic stem cells. My independent research group has now shown that cooperative transcription factor binding mediates hemogenic induction and pioneered cell fate reprogramming approaches in immunology with induced dendritic cells. This conceptual shift opens exciting opportunities to merge cellular reprogramming and cancer immunotherapy.
Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds.
Cellular immunology Jul, 2003 | Pubmed ID: 14572797
Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming.
Journal of cell science May, 2006 | Pubmed ID: 16638804
Heterokaryon-based reprogramming for pluripotency.
Current protocols in stem cell biology Apr, 2009 | Pubmed ID: 19382123
Reprogramming cell fates: insights from combinatorial approaches.
Annals of the New York Academy of Sciences Aug, 2012 | Pubmed ID: 22901251
Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2012 | Pubmed ID: 22988117
Induction of a hemogenic program in mouse fibroblasts.
Cell stem cell Aug, 2013 | Pubmed ID: 23770078
"There will be blood" from fibroblasts.
Cell cycle (Georgetown, Tex.) , 2014 | Pubmed ID: 24335410
'From blood to blood': de-differentiation of hematopoietic progenitors to stem cells.
The EMBO journal Jul, 2014 | Pubmed ID: 24907133
Tbx3 Controls Dppa3 Levels and Exit from Pluripotency toward Mesoderm.
Stem cell reports Jul, 2015 | Pubmed ID: 26095607
Making a Hematopoietic Stem Cell.
Trends in cell biology Mar, 2016 | Pubmed ID: 26526106
Hematopoietic Reprogramming In Vitro Informs In Vivo Identification of Hemogenic Precursors to Definitive Hematopoietic Stem Cells.
Developmental cell Mar, 2016 | Pubmed ID: 26954547
The stem cell niche finds its true north.
Development (Cambridge, England) Aug, 2016 | Pubmed ID: 27531947
Cooperative Transcription Factor Induction Mediates Hemogenic Reprogramming.
Cell reports 12, 2018 | Pubmed ID: 30517869
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.
Science immunology 12, 2018 | Pubmed ID: 30530727
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.
FEBS letters Sep, 2019 | Pubmed ID: 31557312
Michael G. Daniel1,2,3,
Carlos-Filipe Pereira4,
Jeffrey M. Bernitz1,2,3,
Ihor R. Lemischka1,3,5,
Kateri Moore1,3
1Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai,
2The Graduate School of Biomedical Science, Icahn School of Medicine at Mount Sinai,
3Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai,
4Center for Neuroscience and Cell Biology, University of Coimbra,
5Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai
Rita Silvério-Alves1,2,3,
Andreia M. Gomes3,
Ilia Kurochkin4,
Kateri A. Moore5,6,
Carlos-Filipe Pereira1,2,3
1Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University,
2Wallenberg Center for Molecular, Lund University,
3Center for Neuroscience and Cell Biology, University of Coimbra,
4, Skolkovo Institute of Science and Technology,
5Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai,
6Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados